Rituximab combination therapy in relapsing multiple sclerosis
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - Therapeutic Advances in …, 2012 - profiles.wustl.edu
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
[PDF][PDF] Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - 2012 - researchgate.net
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
[PDF][PDF] Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - 2012 - Citeseer
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - Therapeutic advances …, 2012 - pubmed.ncbi.nlm.nih.gov
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
[HTML][HTML] Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - Therapeutic Advances in …, 2012 - ncbi.nlm.nih.gov
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
[PDF][PDF] Rituximab combination therapy in relapsing multiple sclerosis
AH Cross, RS Klein, L Piccio - 2012 - academia.edu
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
Rituximab combination therapy in relapsing multiple sclerosis.
AH Cross, RS Klein, L Piccio - Therapeutic Advances in …, 2012 - europepmc.org
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
Rituximab combination therapy in relapsing multiple sclerosis.
AH Cross, RS Klein, L Piccio - Therapeutic Advances in …, 2012 - europepmc.org
In multiple sclerosis (MS), the presence of B cells, plasma cells and excess
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …
immunoglobulins in central nervous system lesions and in the cerebrospinal fluid implicate …